Conghua Lu

Publication Activity (10 Years)

Years Active: 2020-2022
Publications (10 Years): 4

Top Topics

Epidermal Growth Factor Receptor

Small Cell Lung Cancer

Top Venues

International journal of general medicine

Cell death discovery

Molecular oncology

Communications biology

This page only lists publications with an associated author ORCID identifier.

Publications

Conghua Lu, Rui Yu, Chong Zhang, Caiyu Lin, Yuanyao Dou, Di Wu, Yonghong Pan, Tao Peng, Huan Tang, Rui Han, Yong He
Protective autophagy decreases lorlatinib cytotoxicity through Foxo3a-dependent inhibition of apoptosis in NSCLC. Cell death discovery 8 (1) (2022)
Li Li, Zhujun Li, Conghua Lu, Jianghua Li, Kejun Zhang, Caiyu Lin, Xiaolin Tang, Zhulin Liu, Yimin Zhang, Rui Han, Yubo Wang, Mingxia Feng, Yuan Zhuang, Chen Hu, Yong He
Ibrutinib reverses IL-6-induced osimertinib resistance through inhibition of Laminin α5/FAK signaling. Communications biology 5 (1) (2022)
Yubo Wang, Rui Han, Qiushi Wang, Jie Zheng, Caiyu Lin, Conghua Lu, Li Li, Hengyi Chen, Rongbing Jin, Yong He
Biological Significance of 18F-FDG PET/CT Maximum Standard Uptake Value for Predicting EGFR Mutation Status in Non-Small Cell Lung Cancer Patients. International journal of general medicine 14 (2021)
Rui Han, Shuai Hao, Conghua Lu, Chong Zhang, Caiyu Lin, Li Li, Yubo Wang, Chen Hu, Yong He
Aspirin sensitizes osimertinib-resistant NSCLC cells in vitro and in vivo via Bim-dependent apoptosis induction. Molecular oncology 14 (6) (2020)